Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake

Carbohydrate Polymers

Volumn 90, Issue 1, 2012, Pages 16-22

  Liu, Jinsong ^a   Xu, Lihua ^a   Liu, Chuantong ^a   Zhang, Dafeng ^a   Wang, Siqian ^a   Deng, Zhennan ^a   Lou, Weiwei ^a   Xu, Haihong ^a   Bai, Qing ^a   Ma, Jianfeng ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cell uptake; Chitosan PCL; Curcumin; In vitro cytotoxicity; Nanoparticles

Indexed keywords

CANCER CELLS; CAPROLACTONE; CATIONIC NANOPARTICLES; CELL UPTAKE; CELL VIABILITY; CELLULAR UPTAKE; CURCUMIN; DRUG CONCENTRATION; FLUORESCENCE SPECTRAL ANALYSIS; HELA CELL; IN-VITRO; PH VALUE; SPHERICAL SHAPE; SUSTAINED RELEASE;

DERIVATIVES; PRECIPITATION (CHEMICAL); SPECTRUM ANALYSIS; ZETA POTENTIAL;

NANOPARTICLES;

ANTINEOPLASTIC AGENT; CATION; CHITOSAN; CURCUMIN; DELAYED RELEASE FORMULATION; NANOPARTICLE; POLYCAPROLACTONE; POLYESTER;

CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; HELA CELL LINE; HUMAN; NEOPLASMS; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; CATIONS; CELL SURVIVAL; CHITOSAN; CURCUMIN; DELAYED-ACTION PREPARATIONS; HELA CELLS; HUMANS; NANOPARTICLES; NEOPLASMS; POLYESTERS;

EID: 84864125452     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2012.04.036     Document Type: Article

References (33)

1. B.B. Aggarwal, and K.B. Harikumar Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases The International Journal of Biochemistry & Cell Biology 41 1 2009 40 59
2. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: Problems and promises Molecular Pharmceutics 4 6 2007 807 818
3. P. Anand, H.B. Nair, B. Sung, A.B. Kunnumakkara, V.R. Yadav, and R.R. Tekmal Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo Biochemical Pharmacology 79 3 2010 330 338
4. G. Bar-Sela, R. Epelbaum, and M. Schaffer Curcumin as an anti-cancer agent: Review of the gap between basic and clinical applications Current Medicinal Chemistry 17 3 2010 190 197
5. M.A. Benoit, B. Baras, and J. Gillard Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery International Journal of Pharmaceutics 184 1 1999 73 84
6. E. Bilensoy, C. Sarisozen, G. EsendaglI., A.L. Dogan, Y. Aktas, and M. Sen Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors International Journal of Pharmaceutics 371 1-2 2009 170 176
7. L. Brannon-Peppas, and J.O. Blanchette Nanoparticle and targeted systems for cancer therapy Advanced Drug Delivery Reviews 56 11 2004 1649 1659
8. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Advanced Drug Delivery Reviews 54 5 2002 631 651
9. J.S. Chawla, and M.M. Amiji Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen International Journal of Pharmaceutics 249 1-2 2002 127 138
10. T. Feczko, J. Toth, and J. Gyenis Comparison of the preparation of PLGA-BSA nano-and microparticles by PVA, poloxamer and PVP Colloids and Surfaces A: Physicochemical and Engineering Aspects 319 1-3 2008 188 195
11. W. Glienke, L. Maute, J. Wicht, and L. Bergmann Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression Cancer Investigation 28 2 2009 166 171
12. M.L. Gou, K. Men, H.S. Shi, M.L. Xiang, J. Zhang, and J. Song Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo Nanoscale 3 3 2011 1558 1567
13. L. Ilium Chitosan and its use as a pharmaceutical excipient Pharmaceutical Research 15 9 1998 1326 1331
14. I. Jutooru, G. Chadalapaka, P. Lei, and S. Safe Inhibition of NFκB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation Journal of Biological Chemistry 285 33 2010 25332 25344
15. J.H. Kim, Y.S. Kim, K. Park, S. Lee, H.Y. Nam, and K.H. Min Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice Journal of Controlled Release 127 1 2008 41 49
16. T.H. Kim, H.H. Jiang, Y.S. Youn, C.W. Park, K.K. Tak, and S. Lee Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity International Journal of Pharmaceutics 403 1-2 2011 285 291
17. A.B. Kunnumakkara, P. Anand, and B.B. Aggarwal Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins Cancer Letters 269 2 2008 199 225
18. M.S. Lin, Y.H. Lee, W.T. Chiu, and K.S. Hung Curcumin provides neuroprotection after spinal cord injury Journal of Surgical Research 166 2 2011 280 289
19. S.S. Lin, K.C. Lai, S.C. Hsu, J.S. Yang, C.L. Kuo, and J.P. Lin Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and vascular endothelial growth factor (VEGF) Cancer Letters 285 2 2009 127 133
20. Y.G. Lin, A.B. Kunnumakkara, A. Nair, W.M. Merritt, L.Y. Han, and G.N. Armaiz-Pena Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway Clinical Cancer Research 13 11 2007 3423 3430
21. R.K. Maheshwari, A.K. Singh, J. Gaddipati, and R.C. Srimal Multiple biological activities of curcumin: A short review Life Sciences 78 18 2006 2081 2087
22. C. Mohanty, S. Acharya, A.K. Mohanty, F. Dilnawaz, and S.K. Sahoo Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: A novel controlled delivery vehicle for cancer therapy Nanomedicine 5 3 2010 433 449
23. C. Mohanty, and S.K. Sahoo The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 31 25 2010 6597 6611
24. S.C. Neves, L.S. Moreira Teixeira, L. Moroni, R.L. Reis, C.A. Van Blitterswijk, and N.M. Alves Chitosan/poly(ε-caprolactone) blend scaffolds for cartilage repair Biomaterials 32 4 2011 1068 1079
25. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nature Nanotechnology 2 12 2007 751 760
26. M. Rinaudo Chitin and chitosan: Properties and applications Progress in Polymer Science 31 7 2006 603 632
27. A. Sahu, N. Kasoju, and U. Bora Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells Biomacromolecules 9 10 2008 2905 2912
28. J. Shaikh, D.D. Ankola, V. Beniwal, D. Singh, and M.N.V. Kumar Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer European Journal of Pharmaceutical Sciences 37 3-4 2009 223 230
29. X. Shuai, H. Ai, N. Nasongkla, S. Kim, and J. Gao Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery Journal of Controlled Release 98 3 2004 415 426
30. K. Tahara, T. Sakai, H. Yamamoto, H. Takeuchi, and Y. Kawashima Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery International Journal of Pharmaceutics 354 1 2008 210 216
31. Z.H. Wang, Z.Y. Wang, C.S. Sun, C.Y. Wang, T.Y. Jiang, and S.L. Wang Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain Biomaterials 31 5 2010 908 915
32. R. Yang, S.G. Yang, W.S. Shim, F. Cui, G. Cheng, and I.W. Kim Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates Journal of Pharmaceutical Sciences 98 3 2009 970 984
33. L. Zhu, J. Ma, N. Jia, Y. Zhao, and H. Shen Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: Preparation, characterization and cytotoxicity studies Colloids and Surfaces B: Biointerfaces 68 1 2009 1 6